Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page
- Check4 days agoChange DetectedChanges are UI/formatting updates (glossary display option, color-coded highlights for additions and deletions, and the revision label updated to v3.4.0); there is no impact on core study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe record history shows a new Revision: v3.3.4 replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check39 days agoChange DetectedA new revision entry (v3.3.3) was added to the record history, and the HHS Vulnerability Disclosure and a prior revision link were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check68 days agoChange DetectedThe page history shows a new revision entry v3.3.2 and removes v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check75 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%
- Check89 days agoChange DetectedRecord history shows updates to Study Status and Recruitment Status across multiple versions, with changes to Contacts/Locations. These entries reflect ongoing monitoring of the trial’s progress and point of contact information.SummaryDifference0.1%
Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.